Splenic Marginal Zone Lymphoma with Prominent Myelofibrosis Mimicking Triple-Negative Primary Myelofibrosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Splenic Marginal Zone Lymphoma with Prominent Myelofibrosis Mimicking Triple-Negative Primary Myelofibrosis ; volume:12 ; number:3 ; year:2019 ; pages:834-837
Case reports in oncology ; 12, Heft 3 (2019), 834-837
- Urheber
-
Tsutsui, Miyuki
Yasuda, Hajime
Ota, Yasunori
Komatsu, Norio
- DOI
-
10.1159/000504129
- URN
-
urn:nbn:de:101:1-2020011600121602515932
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tsutsui, Miyuki
- Yasuda, Hajime
- Ota, Yasunori
- Komatsu, Norio
Ähnliche Objekte (12)
Myelofibrosis
Splenic irradiation before allogeneic stem cell transplantation for myelofibrosis
Novel approaches in myelofibrosis
Myelofibrosis Treatment Algorithm 2018
Prefibrotic myelofibrosis: treatment algorithm 2018
Management of myelofibrosis after ruxolitinib failure
Concerns regarding myelofibrosis-type megakaryocyte dysplasia
Myelofibrosis treatment history and future prospects
Prognostic and Predictive Models in Myelofibrosis
Infantile Myelofibrosis and Myeloproliferation with CDC42 Dysfunction
JAK Inhibitors for Myelofibrosis: Strengths and Limitations
Biological drivers of clinical phenotype in myelofibrosis
Myelofibrosis
Splenic irradiation before allogeneic stem cell transplantation for myelofibrosis
Novel approaches in myelofibrosis
Myelofibrosis Treatment Algorithm 2018
Prefibrotic myelofibrosis: treatment algorithm 2018
Management of myelofibrosis after ruxolitinib failure
Concerns regarding myelofibrosis-type megakaryocyte dysplasia
Myelofibrosis treatment history and future prospects
Prognostic and Predictive Models in Myelofibrosis
Infantile Myelofibrosis and Myeloproliferation with CDC42 Dysfunction
JAK Inhibitors for Myelofibrosis: Strengths and Limitations
Biological drivers of clinical phenotype in myelofibrosis
Myelofibrosis
Splenic irradiation before allogeneic stem cell transplantation for myelofibrosis
Novel approaches in myelofibrosis
Myelofibrosis Treatment Algorithm 2018
Prefibrotic myelofibrosis: treatment algorithm 2018
Management of myelofibrosis after ruxolitinib failure
Concerns regarding myelofibrosis-type megakaryocyte dysplasia
Myelofibrosis treatment history and future prospects
Prognostic and Predictive Models in Myelofibrosis
Infantile Myelofibrosis and Myeloproliferation with CDC42 Dysfunction
JAK Inhibitors for Myelofibrosis: Strengths and Limitations